These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25109258)

  • 1. Complement activation in patients with neuromyelitis optica.
    Nytrova P; Potlukova E; Kemlink D; Woodhall M; Horakova D; Waters P; Havrdova E; Zivorova D; Vincent A; Trendelenburg M
    J Neuroimmunol; 2014 Sep; 274(1-2):185-91. PubMed ID: 25109258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
    Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z
    Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
    Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
    J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
    J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA; Gonçalves CA; Portela LV; Saiz-Hinarejos A; Oses JP; Motta LS; Muller AP; Marquez Gonzalez ME; Souza DO
    Neuroimmunomodulation; 2010; 17(3):177-9. PubMed ID: 20134196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ
    Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble C5b-9 in CSF of neuromyelitis optica.
    Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
    Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
    Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.
    Tüzün E; Kürtüncü M; Türkoğlu R; Içöz S; Pehlivan M; Birişik O; Eraksoy M; Akman-Demir G
    J Neuroimmunol; 2011 Apr; 233(1-2):211-5. PubMed ID: 21215465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population.
    Smith CH; Waubant E; Langer-Gould A
    J Neuroophthalmol; 2009 Jun; 29(2):104-6. PubMed ID: 19491632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of neuromyelitis optica.
    Wingerchuk DM; Lennon VA; Lucchinetti CF; Pittock SJ; Weinshenker BG
    Lancet Neurol; 2007 Sep; 6(9):805-15. PubMed ID: 17706564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
    Kim JS; Cheon S; Kim SW; Kim B; Kim H; Park KD; Kim SM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):553-8. PubMed ID: 27462020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
    Kalluri SR; Illes Z; Srivastava R; Cree B; Menge T; Bennett JL; Berthele A; Hemmer B
    Arch Neurol; 2010 Oct; 67(10):1201-8. PubMed ID: 20937947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Yoshikura N; Kimura A; Hayashi Y; Inuzuka T
    J Neuroimmunol; 2017 Sep; 310():150-157. PubMed ID: 28756870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.